These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7280804)

  • 1. [Direct results of using a new multimodal chemotherapy plan in malignant non-Hodgkin lymphomas].
    Tolmacheva EL; Arkhipova NE; Tentsova IA; Chernova MK; Burova GF
    Sov Med; 1981; (6):82-3. PubMed ID: 7280804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results in malignant lymphomas treated by the COPP and POPP drug administration schedules].
    Iavorkovskiĭ LI; Rotsena AIa; Udris OIu; Bliumental' RIa; Zile MA
    Vopr Onkol; 1981; 27(4):34-9. PubMed ID: 6972123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
    Kolarić K; Tomek R; Roth A
    Lijec Vjesn; 1980 Jun; 102(6):306-9. PubMed ID: 7453477
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of leukemic non-Hodgkin lymphoma with DIC, which was induced into complete remission by DCOP-therapy (author's transl)].
    Nakanishi S; Yamazaki H; Kono Y; Nakata T; Nishio A; Haruyama H; Katsuki A; Nakagawa M; Sugishima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1981 Jun; 22(6):896-902. PubMed ID: 7334616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with procarbazine in malignant lymphomas--single and combination (VENP) therapy].
    Shimoyama M; Kitahara T; Sakano T; Konda C; Sakai Y
    Rinsho Ketsueki; 1973 Jun; 14(6):668-75. PubMed ID: 4738281
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas].
    Jandl H; Franke A; Kammerer R; Spormann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):678-84. PubMed ID: 6172333
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
    Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H
    Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350
    [No Abstract]   [Full Text] [Related]  

  • 8. The indication for chemotherapy in the lymphomas.
    Rosenberg SA
    Proc Natl Cancer Conf; 1970; 6():83-9. PubMed ID: 5458149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant lymphoma with Peptichemio. Preliminary communication].
    Uszyński L; Maj S; Pawelski S
    Acta Haematol Pol; 1974; 5(2):153-7. PubMed ID: 4599294
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of non-Hodgkin malignant lymphomas].
    Sans-Sabrafen J
    Med Clin (Barc); 1981 Jan; 76(1):26-9. PubMed ID: 7218926
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical analysis of therapeutic results in malignant non-Hodgkin lymphomas].
    Gociu M; Butoianu E; Munteanu N; Coliţă D; Stoica I; Dosius L; Munţiu R; Guran M; Gheorghiţă E; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):521-30. PubMed ID: 6113671
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 13. [The efficacy of intralymphatic use of antiblastic drugs].
    Stengrevits AA
    Vopr Onkol; 1969; 15(3):3-8. PubMed ID: 5002346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polychemotherapy of malignant lymphomas].
    Vermel' AE; Raevskiĭ IG
    Sov Med; 1976 Aug; (8):42-7. PubMed ID: 1006422
    [No Abstract]   [Full Text] [Related]  

  • 15. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences in the treatment of non-Hodgkin lymphomas].
    Kiss A; Jakó J; Telek B; Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):685-90. PubMed ID: 6172334
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant lymphomas. Non-Hodgkin's lymphomas (NHL). II. Therapeutic planning].
    Neretto G
    Minerva Med; 1980 Apr; 71(13):996-8. PubMed ID: 7375012
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic lympholeukemia patients with a combination of pafencil and cyclophosphane].
    Iavorkovskiĭ LI; Grasmane DV; Iavorskiĭ LL; Zile MA; Sakson MP
    Gematol Transfuziol; 1983 Apr; 28(4):7-11. PubMed ID: 6852517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advantages and hazards of combined chemotherapy in malignant lymphomas (author's transl)].
    Klener P; Donner L
    Sb Lek; 1978 Jun; 80(6):185-9. PubMed ID: 675144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined chemotherapy for malignant lymphomas (author's transl)].
    Zhou JC; Sun Y; Ye ZS; Xin MZ
    Zhonghua Zhong Liu Za Zhi; 1980 Dec; 2(4):300-3. PubMed ID: 7297405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.